Muscle-invasive Bladder Cancer

Also known as: Muscle Invasive Bladder Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB18442ABSK-0911Active Not Recruiting1
DB11740Adavosertib1Active Not Recruiting1
DB14825Danvatirsen1Active Not Recruiting1
DB11714Durvalumab1Active Not Recruiting1
DB11714Durvalumab1Completed1
DB09074Olaparib1Active Not Recruiting1
DB15088Oleclumab1Completed1
DB11689Selumetinib1Active Not Recruiting1
DB11925Vistusertib1Active Not Recruiting1
DB14922Tislelizumab1 / 2Recruiting1
DB11945Avelumab2Recruiting1
DB00515Cisplatin2Completed3
DB17208Disitamab vedotin2Recruiting1
DB00997Doxorubicin2Completed2
DB00997Doxorubicin2Unknown Status1
DB11714Durvalumab2Terminated1
DB11717Epacadostat2Withdrawn1
DB00441Gemcitabine2Completed1
DB00563Methotrexate2Completed2
DB09035Nivolumab2Completed1
DB01229Paclitaxel2Active Not Recruiting1
DB00019Pegfilgrastim2Completed1
DB09037Pembrolizumab2Withdrawn1
DB12257Platinum2Completed1
DB12332Rucaparib2Terminated1
DB14922Tislelizumab2Active Not Recruiting1
DB15043Toripalimab2Recruiting2
DB11771Tremelimumab2Terminated1
DB00570Vinblastine2Completed2
DB11595Atezolizumab3Recruiting1
DB15140Bempegaldesleukin3Completed1
DB00515Cisplatin3Active Not Recruiting2
DB11714Durvalumab3Active Not Recruiting1
DB11714Durvalumab3Recruiting1
DB13007Enfortumab vedotin3Recruiting1
DB00441Gemcitabine3Active Not Recruiting2
DB09035Nivolumab3Active Not Recruiting1
DB09035Nivolumab3Completed1
DB11771Tremelimumab3Recruiting1